<SEC-DOCUMENT>0001104659-15-025547.txt : 20150402
<SEC-HEADER>0001104659-15-025547.hdr.sgml : 20150402
<ACCEPTANCE-DATETIME>20150402163426
ACCESSION NUMBER:		0001104659-15-025547
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20150331
FILED AS OF DATE:		20150402
DATE AS OF CHANGE:		20150402

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mylan N.V.
		CENTRAL INDEX KEY:			0001623613
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				981189497
		STATE OF INCORPORATION:			P7
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		ALBANY GATE, DARKES LANE
		CITY:			POTTERS BAR, HERTS
		STATE:			X0
		ZIP:			EN6 1AG
		BUSINESS PHONE:		44 0 1707 853 000

	MAIL ADDRESS:	
		STREET 1:		ALBANY GATE, DARKES LANE
		CITY:			POTTERS BAR, HERTS
		STATE:			X0
		ZIP:			EN6 1AG

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	New Moon B.V.
		DATE OF NAME CHANGE:	20141028

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Abbott Investments Luxembourg S.A R.L.
		CENTRAL INDEX KEY:			0001635614

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-199861
		FILM NUMBER:		15748167

	BUSINESS ADDRESS:	
		STREET 1:		100 ABBOTT PARK ROAD
		STREET 2:		AP6A-2, D-032L
		CITY:			ABBOTT PARK
		STATE:			IL
		ZIP:			60064-6092
		BUSINESS PHONE:		224-668-3591

	MAIL ADDRESS:	
		STREET 1:		100 ABBOTT PARK ROAD
		STREET 2:		AP6A-2, D-032L
		CITY:			ABBOTT PARK
		STATE:			IL
		ZIP:			60064-6092

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Abbott Established Products Holdings Gibraltar Ltd
		CENTRAL INDEX KEY:			0001635611

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-199861
		FILM NUMBER:		15748168

	BUSINESS ADDRESS:	
		STREET 1:		100 ABBOTT PARK ROAD
		STREET 2:		AP6A-2, D-032L
		CITY:			ABBOTT PARK
		STATE:			IL
		ZIP:			60064-6092
		BUSINESS PHONE:		224-668-3591

	MAIL ADDRESS:	
		STREET 1:		100 ABBOTT PARK ROAD
		STREET 2:		AP6A-2, D-032L
		CITY:			ABBOTT PARK
		STATE:			IL
		ZIP:			60064-6092

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Laboratoires Fournier S.A.S.
		CENTRAL INDEX KEY:			0001635767

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-199861
		FILM NUMBER:		15748169

	BUSINESS ADDRESS:	
		STREET 1:		100 ABBOTT PARK ROAD
		STREET 2:		AP6A-2, D-032L
		CITY:			ABBOTT PARK
		STATE:			IL
		ZIP:			60064-6092
		BUSINESS PHONE:		224-668-3591

	MAIL ADDRESS:	
		STREET 1:		100 ABBOTT PARK ROAD
		STREET 2:		AP6A-2, D-032L
		CITY:			ABBOTT PARK
		STATE:			IL
		ZIP:			60064-6092

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			ABBOTT LABORATORIES
		CENTRAL INDEX KEY:			0000001800
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		STATE OF INCORPORATION:			IL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-199861
		FILM NUMBER:		15748170

	BUSINESS ADDRESS:	
		STREET 1:		100 ABBOTT PARK ROAD
		STREET 2:		D-322 AP6D
		CITY:			ABBOTT PARK
		STATE:			IL
		ZIP:			60064-3500
		BUSINESS PHONE:		8479376100
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>a4.xml
<DESCRIPTION>4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2015-03-31</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001623613</issuerCik>
        <issuerName>Mylan N.V.</issuerName>
        <issuerTradingSymbol>MYL</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0000001800</rptOwnerCik>
            <rptOwnerName>ABBOTT LABORATORIES</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>100 ABBOTT PARK ROAD</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>ABBOTT PARK</rptOwnerCity>
            <rptOwnerState>IL</rptOwnerState>
            <rptOwnerZipCode>60064-6092</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001635767</rptOwnerCik>
            <rptOwnerName>Laboratoires Fournier S.A.S.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>100 ABBOTT PARK ROAD</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>ABBOTT PARK</rptOwnerCity>
            <rptOwnerState>IL</rptOwnerState>
            <rptOwnerZipCode>60064-6092</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001635611</rptOwnerCik>
            <rptOwnerName>Abbott Established Products Holdings Gibraltar Ltd</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>100 ABBOTT PARK ROAD</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>ABBOTT PARK</rptOwnerCity>
            <rptOwnerState>IL</rptOwnerState>
            <rptOwnerZipCode>60064-6092</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001635614</rptOwnerCik>
            <rptOwnerName>Abbott Investments Luxembourg S.A R.L.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>100 ABBOTT PARK ROAD</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>ABBOTT PARK</rptOwnerCity>
            <rptOwnerState>IL</rptOwnerState>
            <rptOwnerZipCode>60064-6092</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Ordinary Shares, nominal value euro 0.01 per share</value>
            </securityTitle>
            <transactionDate>
                <value>2015-03-31</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>J</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>35000000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>56.8912</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>75000000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By Subsidiaries</value>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Call Option (Obligation to Sell)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>56.8912</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2015-03-31</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>J</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>1</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2015-03-31</value>
            </exerciseDate>
            <expirationDate>
                <value>2015-04-30</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Ordinary Shares</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>5250000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By Subsidiaries</value>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <remarks>The Ordinary Shares of Mylan N.V. (&quot;Mylan&quot;) described in this report are held directly by Laboratoires Fournier S.A.S., Abbott Established Products Holdings (Gibraltar) Limited and Abbott Investments Luxembourg S.a r.l (collectively, the &quot;Subsidiaries&quot;). Each of the Subsidiaries is an indirect, wholly-owned subsidiary of Abbott Laboratories (&quot;Abbott&quot;). In Abbott's capacity as the ultimate corporate parent of the Subsidiaries, Abbott may be deemed to indirectly beneficially own such Ordinary Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and regulations of the Securities and Exchange Commission thereunder. On March 31, 2015, the Subsidiaries entered into an Underwriting Agreement (the &quot;Underwriting Agreement&quot;) with Morgan Stanley &amp; Co. LLC and Goldman Sachs &amp; Co., as representatives of the several underwriters named therein, and Mylan relating to an underwritten public resale offering by the Subsidiaries of an aggregate of  35,000,000 Ordinary Shares.  The purchase price to be received by the Subsidiaries pursuant to the Underwriting Agreement is $56.89125 per Ordinary Share.  Pursuant to the Underwriting Agreement, Abbott Investments Luxembourg S.a r.l, for no additional consideration, granted the underwriters a 30-day option to purchase up to an additional 5,250,000 Ordinary Shares at the same price per Ordinary Share.</remarks>

    <ownerSignature>
        <signatureName>ABBOTT LABORATORIES Thomas C. Freyman</signatureName>
        <signatureDate>2015-03-31</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
